An Ozempic overdose lawsuit claims a man was hospitalized with severe injuries after a Giant Pharmacy accidentally gave him too high a dose of the diabetes drug.
A new report reveals FDA inspectors found a lack of adequate microbial controls at a Novo Nordisk plant in the U.S., which manufactures the active ingredient for Ozempic and Wegovy.
Some anesthesiologists are saying recent ASA guidelines don't go far enough to prevent Ozempic stomach risks during surgery.
Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
The makers of Wegovy claim the weight loss drug can decrease the risk of serious heart problems, such as stroke and heart attacks.
Eli Lilly may face a growing number of Mounjaro lawsuits, as users of the new drug report increasing incidents of stomach paralysis linked to the diabetes medication.
A gastroparesis lawsuit filed against the makers of Ozempic and Mounjaro claim the diabetes injections should warn patients and their doctors of the risks of severe stomach problems.
The side effects of Ozempic and Wegovy may be linked to cases of stomach paralysis, due to the drugs' ability to hinder digestion, according to a new report.
European regulators have launched an investigation into Ozempic suicide risks following reports of users experiencing desires to harm themselves in Iceland.
New guidance calls for patients to stop taking Ozempic, Wegovy and similar drugs before surgery due to risks of vomiting and suffocation.
